Small-Cap catch-up: KAPE, ITIM and HSP
Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small-cap equities.
Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small-cap equities.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
The trilemma is how to achieve energy security with sufficient, continuous capacity while eliminating CO2 emissions. The only way to achieve this is through advances in technology, says Victor Hill.
Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small-cap equities.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Robert Stephens, CFA, discusses the outlook for AstraZeneca and Smith & Nephew.
Financial markets are on a roller coaster this year. On the one hand, we have very unfavourable macro and geopolitical conditions. But, on the other hand, the ‘bulls keep buying the dips’.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
The need to think more broadly has seen an increasing number of investors move away from traditional investments and seek alternative “hard” assets, such as fine wine, whose underlying intrinsic value tends to drive greater resilience during turbulent and inflationary times.
Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small-cap equities.